The new indifference towards the small price fluctuations of ENZO BIOCHEM INC could raise concerns from stakeholders as the firm is trading at a share price of 0.0 on very low momentum in volume. The company management teams did not add any value to ENZO BIOCHEM investors in July. However, most investors can still diversify their portfolios with ENZO BIOCHEM INC to hedge their inherited risk against high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently very low. The very small Stock volatility is a good signal to stakeholders with longer-term investment horizons.
Check out Trending Equities.
The ENZO BIOCHEM stock analysis report makes it easy to digest most publicly released information about ENZO BIOCHEM and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ENZO BIOCHEM Stock analysis module also helps to analyze the ENZO BIOCHEM price relationship with some important fundamental indicators such as market cap and management efficiency.

ENZO BIOCHEM Stock Analysis Notes

The book value of the company was presently reported as 1.83. The company recorded a loss per share of 0.09. ENZO BIOCHEM INC had not issued any dividends in recent years. Enzo Biochem, Inc., an integrated diagnostic bioscience company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. Enzo Biochem, Inc. was founded in 1976 and is headquartered in New York, New York. Momina Krepost is traded on London Stock Exchange in UK. For more info on ENZO BIOCHEM INC please contact Elazar Rabbani at 212-583-0100 or go to http://www.enzo.com.

ENZO BIOCHEM INC Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ENZO BIOCHEM's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ENZO BIOCHEM INC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ENZO BIOCHEM INC is not yet fully synchronised with the market data
ENZO BIOCHEM INC has some characteristics of a very speculative penny stock
ENZO BIOCHEM INC has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 108.43 M. Net Loss for the year was (4.46 M) with profit before overhead, payroll, taxes, and interest of 48.33 M.

ENZO BIOCHEM Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 260.83 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ENZO BIOCHEM's market, we take the total number of its shares issued and multiply it by ENZO BIOCHEM's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

ENZO BIOCHEM Profitablity

ENZO BIOCHEM's profitability indicators refer to fundamental financial ratios that showcase ENZO BIOCHEM's ability to generate income relative to its revenue or operating costs. If, let's say, ENZO BIOCHEM is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, ENZO BIOCHEM's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of ENZO BIOCHEM's profitability requires more research than a typical breakdown of ENZO BIOCHEM's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (4.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (6.38) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.06.

Management Efficiency

The entity has return on total asset (ROA) of (4.08) % which means that it has lost $4.08 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (5.1) %, meaning that it generated substantial loss on money invested by shareholders. ENZO BIOCHEM management efficiency ratios could be used to measure how well enzo biochem inc manages its routine affairs as well as how well it operates its assets and liabilities.

ENZO BIOCHEM Technical and Predictive Indicators

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ENZO BIOCHEM to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Crypto Correlations Now


Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module
Check out Trending Equities. Note that the ENZO BIOCHEM INC information on this page should be used as a complementary analysis to other ENZO BIOCHEM's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Tools for ENZO BIOCHEM Stock

When running ENZO BIOCHEM INC price analysis, check to measure ENZO BIOCHEM's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ENZO BIOCHEM is operating at the current time. Most of ENZO BIOCHEM's value examination focuses on studying past and present price action to predict the probability of ENZO BIOCHEM's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ENZO BIOCHEM's price. Additionally, you may evaluate how the addition of ENZO BIOCHEM to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities